Patient-centered focus The Brod Group specializes in patient voice driven health outcomes and late phase research, presenting opportunities to offer expanded patient-centered PRO development and post-launch research services to pharma and biotech clients seeking patient-centric evidence.

Global reach With international experience and a 360-degree perspective across academic, pharmaceutical, and contract research settings, there is potential to position as a flexible, boutique partner for global late phase studies and market access research in diverse regions.

Specialized expertise Deep capabilities in designing and validating PRO measures, health outcomes research, and late phase studies create up-sell paths for add-on methodologies, instrument development, and dissemination of findings in peer-reviewed venues.

SMB to mid-market fit Revenue range and small team size indicate a sweet spot to target mid-market pharma and biotech companies seeking specialized, high-touch research partners for strategic market access planning and patient-centric study design.

Strategic partnerships Strong publication track record and broad stakeholder engagement in health outcomes suggest opportunities to formalize collaborations, alliance-grade studies, and co-authored deliverables with larger CROs or academic networks seeking niche expertise.